Veber; Daniel F.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Veber; Daniel F..The latest application filed is for "protease inhibitors".
Company Profile
0.42.10
- Veber; Daniel F. - Ambler PA
- Veber, Daniel F. - King of Prussia PA
- Veber, Daniel F - Ambler PA
Patent Activity
| Patent | Date |
|---|---|
| Protease inhibitors Grant 7,563,784 - Cummings , et al. July 21, 2 | 2009-07-21 |
| Protease inhibitors App 20060194787 - Cummings; Maxwell D. ; et al. | 2006-08-31 |
| Protease inhibitors Grant 7,071,184 - Cummings , et al. July 4, 2 | 2006-07-04 |
| Protease inhibitors App 20040229863 - Cummings, Maxwell D. ; et al. | 2004-11-18 |
| Inhibitors of cysteine protease App 20040180927 - Marquis, Robert W. JR. ; et al. | 2004-09-16 |
| Protease inhibitors App 20040044201 - Cummings, Maxwell D. ; et al. | 2004-03-04 |
| Protease inhibitors App 20040038965 - Marquis, Jr., Robert W. ; et al. | 2004-02-26 |
| Methods of treatment App 20040034013 - Cummings, Maxwell D ; et al. | 2004-02-19 |
| Protease inhibitors App 20030114437 - Cummings, Maxwell D. ; et al. | 2003-06-19 |
| Method of antagonizing the human SRC SH2 domain App 20030096760 - Yamashita, Dennis S. ; et al. | 2003-05-22 |
| Protease inhibitors Grant 6,566,373 - Gribble , et al. May 20, 2 | 2003-05-20 |
| Inhibitors of cysteine protease App 20020128476 - Marquis, Robert W. JR. ; et al. | 2002-09-12 |
| Protease inhibitors Grant 6,369,077 - Marquis , et al. April 9, 2 | 2002-04-09 |
| Protease inhibitors App 20020013360 - Gribble, Andrew D. ; et al. | 2002-01-31 |
| Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists Grant 5,693,643 - Gilbert , et al. December 2, 1 | 1997-12-02 |
| Thrombin inhibitors Grant 5,672,582 - Veber , et al. September 30, 1 | 1997-09-30 |
| Quinazolinones substituted with phenoxyphenylacetic acid derivatives Grant 5,420,133 - Dhanoa , et al. May 30, 1 | 1995-05-30 |
| Six membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives used to treat asthma Grant 5,374,638 - Dhanoa , et al. December 20, 1 | 1994-12-20 |
| Fibrinogen receptor antagonists Grant 5,340,798 - Nutt , et al. August 23, 1 | 1994-08-23 |
| Peptides having atrial natriuretic factor activity Grant 5,204,328 - Nutt , et al. April 20, 1 | 1993-04-20 |
| Peptides having ANF activity Grant 5,091,366 - Nutt , et al. February 25, 1 | 1992-02-25 |
| Fibrinogen receptor antagonists Grant 5,061,693 - Nutt , et al. October 29, 1 | 1991-10-29 |
| Peptides having ANF activity Grant 5,057,603 - Nutt , et al. October 15, 1 | 1991-10-15 |
| Fibrinogen receptor antagonists Grant 5,023,233 - Nutt , et al. June 11, 1 | 1991-06-11 |
| Analogs of substance P and eledoisin Grant 4,680,283 - Veber , et al. July 14, 1 | 1987-07-14 |
| Renin inhibitory tripeptides Grant 4,668,770 - Boger , et al. May 26, 1 | 1987-05-26 |
| Novel cyclic Hexapeptide LHRH antagonists Grant 4,659,691 - Veber , et al. April 21, 1 | 1987-04-21 |
| Ace inhibitors in macular degeneration Grant 4,656,188 - Veber , et al. April 7, 1 | 1987-04-07 |
| Process for 3-acylamino benzodiazepines Grant 4,628,084 - Bock , et al. December 9, 1 | 1986-12-09 |
| 2(3-Amino-2-oxopyrrolidin-1-yl) acetic acid and n-acylated derivatives thereof Grant 4,493,934 - Veber , et al. January 15, 1 | 1985-01-15 |
| Renin inhibitors containing a C-terminal amide cycle Grant 4,485,099 - Boger , et al. November 27, 1 | 1984-11-27 |
| Renin inhibitory peptides having PHE.sup.13 delection Grant 4,479,941 - Veber , et al. October 30, 1 | 1984-10-30 |
| Renin inhibitory peptides Grant 4,478,826 - Veber , et al. October 23, 1 | 1984-10-23 |
| Renin inhibitors containing a C-terminal disulfide cycle Grant 4,477,441 - Boger , et al. October 16, 1 | 1984-10-16 |
| Renin inhibitors containing an n-terminal disulfide cycle Grant 4,477,440 - Boger , et al. October 16, 1 | 1984-10-16 |
| Renin inhibitory peptides having His.sup.13 Grant 4,470,971 - Boger , et al. September 11, 1 | 1984-09-11 |
| Cyclic octapeptide analogs of neurotensin Grant 4,439,359 - Holly, deceased , et al. March 27, 1 | 1984-03-27 |
| Renin inhibitory peptides Grant 4,384,994 - Veber , et al. May 24, 1 | 1983-05-24 |
| Modified D-retro cyclic hexapeptide somatostatin analogs Grant 4,360,516 - Freidinger , et al. * November 23, 1 | 1982-11-23 |
| Cyclic hexapeptide somatostatin analogs Grant 4,310,518 - Freidinger , et al. January 12, 1 | 1982-01-12 |
| Long-lasting agonists of enkephalin Grant 4,254,107 - Veber , et al. March 3, 1 | 1981-03-03 |
| Cyclic hexapeptide somatostatin analogs Grant 4,235,886 - Freidinger , et al. November 25, 1 | 1980-11-25 |
| Cyclic hexapeptide Grant 4,192,875 - Veber , et al. March 11, 1 | 1980-03-11 |
| Bicyclic somatostatin analogs Grant 4,191,754 - Veber , et al. March 4, 1 | 1980-03-04 |
| Somatostatin analogs Grant 4,146,612 - Veber March 27, 1 | 1979-03-27 |
| Somatostatin analogs Grant 4,140,767 - Veber February 20, 1 | 1979-02-20 |
| Somatostatin analogs Grant 4,139,526 - Veber February 13, 1 | 1979-02-13 |
| Process for preparing somatostatin analog Grant 4,130,554 - Holly , et al. December 19, 1 | 1978-12-19 |
| Somatostatin analogs Grant 4,115,554 - Veber September 19, 1 | 1978-09-19 |
| Cyclic hexapeptides Grant 4,108,987 - Veber , et al. August 22, 1 | 1978-08-22 |
| Analogs of thyrotropin-releasing hormone Grant 3,959,248 - Veber , et al. May 25, 1 | 1976-05-25 |
| Process for preparing e-pyridyl-4-methyloxycarbonyllysine Grant 3,950,348 - Hirschmann , et al. April 13, 1 | 1976-04-13 |
Company Registrations
| NCAGE Code | 4NC41 | VEBER DANIEL F |
| CAGE Code | 4NC41 | VEBER, DANIEL F |
| DUNS | 790593250 | VEBER, DANIEL F |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 